◆ NeutralTEVA
Teva Announces Launch of Offering of Senior Notes
GlobeNewswire Inc.·
Teva Pharmaceutical announced its intention to issue EUR and USD-denominated senior notes through special purpose finance subsidiaries. The company plans to use net proceeds to redeem certain existing notes, including 6.750% notes due 2028, 7.875% and 7.375% sustainability-linked notes due 2029, and portions of 4.750% and 4.375% notes. The offering is subject to market conditions and is not conditioned on the redemptions.
Read Full Article at GlobeNewswire Inc. →